What does Axe Compute do?
Axe Compute Inc. trades on the Nasdaq Capital Market under AGPU. The company operated as Predictive Oncology until December 2025, then repositioned around enterprise GPU infrastructure. Axe sources capacity from hardware suppliers, data centers, and distributed networks; combines it with storage, networking, colocation, financing, and support; and sells the service to enterprises running artificial-intelligence or high-performance-computing workloads. The model is described in its official investor overview.
Which businesses remain inside the company?
The FY2025 Form 10-K reports two segments. Compute Services and Treasury Management is the priority and includes GPU access plus an ATH treasury. Legacy Drug Discovery Services applies predictive methods to a biobank of more than 150,000 tumor samples and develops 3D tumor models. The board is reviewing strategic alternatives, but no transaction was committed in the latest filings.
| Business area | Customer need | Revenue logic | Current strategic role |
|---|---|---|---|
| Compute Services | Rapid access to dedicated or already-online GPU capacity | Per-GPU, per-hour pricing; reserved capacity; storage and CPU services | Core growth platform |
| Treasury Management | Settlement and strategic access within the Aethir ecosystem | ATH holdings, potential staking yield, and token-linked compute economics | Large balance-sheet exposure and liquidity source |
| Drug Discovery Services | Tumor-response prediction, 3D models, and oncology research services | Project and service revenue from biopharma relationships | Non-core legacy business under strategic review |
How does Axe Compute make money?
The intended engine is contract-based compute revenue, not token appreciation. Customers reserve capacity and usually pay in advance; Axe sources and deploys the infrastructure, then recognizes revenue as service is delivered. The structure can reduce receivables risk and match capacity commitments with demand. The transition from asset-light aggregation toward selective GPU ownership, however, raises both margin potential and capital requirements.
Why are take-or-pay contracts important?
Axe's largest announced agreement is a 36-month, approximately $260 million contract for 2,304 NVIDIA B300 GPUs plus storage at a U.S. Tier 3 data center. The April 22, 2026 Form 8-K specifies a deposit, prepayment, and monthly advance payments on a take-or-pay basis. Management expects about $21 million of quarterly revenue after targeted Q3 2026 deployment; this is a forward target, not reported Q1 revenue.
What did the first revenue mix look like?
The mix is useful mainly as a maturity signal. Compute had just begun contributing, while post-quarter contracts were far larger than historical revenue. The test is whether signed capacity becomes deployed infrastructure, recognized revenue, gross profit, and operating cash flow.
What does Axe Compute's latest reported quarter show?
The quarter ended March 31, 2026 predates operation of the largest announced cluster, so it is a transition baseline rather than steady-state earnings. The Q1 2026 Form 10-Q shows small revenue, substantial corporate spending, an ATH mark-to-market loss, and a balance sheet dominated by digital-asset-related items.
Which lines explain the loss?
| Metric | Q1 2026 | Q1 2025 | Interpretation |
|---|---|---|---|
| Revenue | $35,311 | $110,310 | Legacy activity declined; compute contributed only about $7,000 late in the quarter. |
| Cost of revenue | $6,770 | $45,118 | The implied 80.8% gross margin is not representative because revenue was extremely small and mixed across businesses. |
| General and administrative | $2.91M | $1.83M | Higher personnel, professional-service, stock-compensation, and former-CEO severance costs raised the fixed-cost base. |
| Research and development | $0.55M | $0.52M | Cloud-computing and laboratory costs remained material relative to revenue. |
| Loss on digital assets | $(4.30)M | $0 | ATH fair-value changes flowed through earnings and accounted for more than half of the quarterly net loss. |
| Net loss per share | $(0.36) | $(5.12) | The denominator expanded sharply because weighted-average shares include pre-funded warrants. |
One customer represented about 79% of the $659,325 accounts-receivable balance at March 31, 2026. The absolute amount was small, but it foreshadows dependence on a few deployments even with prepayment.
Which turning points created today's Axe Compute?
Axe is a rapid reconstruction of a small public biomedical company, not an established cloud platform with long comparable history. Its assets, reporting systems, warrants, legacy liabilities, and Nasdaq compliance record came from the predecessor organization.
-
Q3 2024The Birmingham operation met discontinued-operations criteria, beginning a narrower focus on the remaining drug-discovery platform.
-
March 2025The Eagan medical-fluid-disposal assets were sold to DeRoyal, removing another legacy operating business and simplifying the portfolio.
-
September 2025The company adopted an ATH-focused treasury strategy and completed a 1-for-15 reverse stock split, addressing listing pressure while changing the balance-sheet thesis.
-
October 2025Two PIPE transactions raised $343.5 million of gross consideration: about $50.8 million in cash and $292.7 million of ATH notional value, recorded at a lower discounted amount for the in-kind contribution.
-
December 2025Predictive Oncology became Axe Compute, and the Nasdaq ticker changed from POAI to AGPU, formally shifting the corporate narrative to AI infrastructure.
-
February-March 2026Christopher Miglino became CEO, Chuck Nuzum became chair, two directors joined, and advisers began reviewing strategic alternatives for Helomics.
-
April-June 2026Axe announced initial commercial agreements, the $260 million B300 contract, and two additional long-term contracts totaling $25.9 million with $12.9 million received in advance.
What did the pivot change economically?
The pivot replaced a low-revenue oncology thesis with a larger infrastructure-contract opportunity, while adding ATH fair-value volatility, a more complex diluted share structure, and an owned-GPU model for major projects. Upside increased together with capital intensity, customer concentration, execution risk, and accounting volatility.
What gives Axe Compute a competitive advantage?
Axe's claimed differentiation is orchestration. It offers immediate third-party capacity for urgent workloads and a build program for dedicated “AI factory” deployments. This can provide more hardware and geographic choice than a fixed fleet. June 2026 contracts covered Blackwell and Grace Blackwell workloads in inference, simulation, robotics, gaming, autonomy, digital twins, and synthetic data.
Who are the relevant competitors?
The 10-K identifies dedicated GPU clouds, AI data-center operators, distributed GPU providers, and hyperscalers as the relevant competitive groups. AWS, Microsoft Azure, and Google Cloud bring balance sheets, software ecosystems, procurement relationships, and global support; specialized neoclouds can offer tailored clusters; distributed networks aggregate fragmented capacity. Axe must win on speed, configuration choice, pricing, reliability, and execution rather than brand scale.
| Competitive group | Typical advantage | Axe response | Main vulnerability |
|---|---|---|---|
| Hyperscale cloud | Integrated cloud stack, global sales, financing capacity | More flexible hardware and location sourcing; no-lock-in positioning | Axe lacks comparable ecosystem depth and customer trust |
| Specialized neoclouds | AI-native operations and dedicated clusters | Immediate-access plus build model across partners | Rivals may have more operating history and owned capacity |
| Distributed GPU networks | Broad capacity aggregation and geographic reach | Public-company wrapper, enterprise contracting, and service support | Dependence on third parties can weaken control over quality |
| Customer self-build | Direct asset control and customized infrastructure | Faster deployment without customers funding full capex upfront | Large customers may internalize capacity once scale is sufficient |
How financially strong is Axe Compute?
At March 31, 2026, current assets of $37.59 million covered $4.23 million of current liabilities 8.9 times. Most were not cash: $20.23 million was ATH and $9.44 million was a token receivable. Cash fell 35.8% to $6.93 million as Q1 operations used $3.75 million.
How concentrated is the liquidity pool?
What does the annual context add?
FY2025 revenue was $125,284, all legacy. Continuing operations lost $232.9 million, including $152.5 million of digital-asset losses, a $52.7 million derivative loss, and $16.6 million of stock compensation. Operating cash use was $9.88 million, investing used $32.62 million, and financing provided $52.01 million. Non-cash charges explain much of the loss, but operations were not self-funding.
| Financial strength indicator | Period and value | Research interpretation |
|---|---|---|
| Cash runway input | $6.93M cash; Q1 2026 | Cash alone was less than two quarters of Q1 operating cash use, before post-quarter customer prepayments. |
| Working capital | $33.37M; March 31, 2026 | Strong headline coverage, but heavily linked to ATH and token receivables. |
| Stockholders' equity | $40.27M; March 31, 2026 | Positive after the PIPE, yet vulnerable to losses, digital-asset changes, and future financing. |
| Simple free-cash-flow proxy | $(3.77)M; Q1 2026 | Operating cash flow minus $21,000 of property purchases; not a company-defined non-GAAP measure. |
| Accumulated deficit | $421.23M; March 31, 2026 | Reflects years of predecessor-company losses and raises the burden of proving a new model. |
Who owns Axe Compute stock, and how does governance matter?
Current filings do not identify a founder with voting control. Ownership is dispersed, so capital structure matters more than a simple holder list. At March 31, 2026, Axe reported 5,539,267 common shares, 79,246 Series B preferred shares, and 1,619,507 ordinary warrants at a $17.39 weighted-average exercise price. The Q1 EPS denominator was 21.18 million because it included about 14.7 million pre-funded warrants.
| Holder or instrument | Economic stake or amount | Source period | Why it matters |
|---|---|---|---|
| Common shares outstanding | 5,539,267 shares | March 31, 2026 | The visible share count understates fully diluted exposure when pre-funded warrants and options are considered. |
| Pre-funded warrants in EPS denominator | Approximately 14.7M | Q1 2026 | These instruments make dilution and per-share valuation central to any analysis. |
| Kyle Okamoto and Okalina Ventures | 244,389 shares; 4.4% | Schedule 13D filed in 2026 | The company president has a meaningful economic stake but not voting control. |
| CEO inducement options | 500,000 options | February 2026 | Links leadership upside to equity value while adding potential dilution. |
| CFO inducement options | 225,000 options at $3.51 | April 2026 | The three-year vesting grant supports retention during the scale-up phase. |
What governance signals should researchers watch?
Christopher Miglino became CEO and a director in February 2026; Kyle Okamoto became president in April; Jeremy Yaukey-Witter became sole CFO after May 18. Axe maintains audit, compensation, and nominating-and-governance committees under its corporate-governance framework. A 2026 Schedule 13D reports Okamoto's 4.4% stake.
Which opportunities could materially change the company?
The opportunity is nonlinear because reported revenue is tiny while announced contracts are large. The $260 million agreement implies about $86.7 million of annualized revenue during its 36-month term if deployed and recognized as expected. Two June 2026 agreements totaled $25.9 million, with $12.9 million received in advance. The official June 16 release describes 12- and 24-month deployments across Blackwell and Grace Blackwell workloads.
Can scale improve the business model?
Scale could improve supplier bargaining, financing, credibility, and support efficiency while combining immediate access with dedicated clusters. Axe reported about $12 million of executed agreements across more than 20 customers and over 30 active deployments entering Q2 2026 in an April 1 commercial update. These were management estimates subject to deployment and performance obligations, so recognized revenue remains the more reliable confirmation metric.
What risks could weaken Axe Compute's outlook?
The June 2026 updated risk factors explicitly acknowledge that owning GPUs is more capital-intensive than the prior asset-light model and exposes Axe to obsolescence, depreciation, impairment, utilization, and financing risk.
| Risk | Financial transmission | What to monitor |
|---|---|---|
| Deployment failure or delay | Revenue starts later; prepayments may not cover all carrying costs; credibility weakens | Hardware delivery, data-center readiness, customer acceptance, Q3 milestones |
| Customer concentration | One default, dispute, or reduced commitment can disproportionately affect revenue and cash flow | Top-customer revenue, receivables, deposits, renewal terms, new-customer diversification |
| GPU obsolescence | Lower pricing, shorter useful lives, accelerated depreciation, or impairment | Utilization by architecture, residual value, upgrade cycle, contract life versus asset life |
| Power and data-center dependence | Outages or insufficient cooling can trigger service failures and penalties | Facility redundancy, uptime, power availability, insurance, concentration by location |
| ATH concentration | Mark-to-market losses reduce earnings and equity; liquidity may deteriorate in stressed markets | Token price, vesting schedule, custody, staking, sale liquidity, regulatory developments |
| Financing and dilution | New equity, warrants, convertibles, or debt can reduce per-share economics | Shelf usage, ATM issuance, warrant exercises, debt terms, fully diluted shares |
| Nasdaq compliance | A future deficiency could lead to hearing costs, uncertainty, or delisting risk | Stockholders' equity, bid price, and the one-year panel-monitor period from December 2025 |
Why is the strategic tension important?
The model now includes buying and operating GPUs for dedicated contracts. Residual value depends on technology progress, power efficiency, resale demand, and redeployment.
Why does Axe Compute's business model matter for valuation?
Historical multiples are weak because FY2025 revenue was legacy and Q1 compute revenue was only $7,000. Valuation must bridge contracts to deployment, revenue, margin after infrastructure costs, capex, asset lives, financing, concentration, and diluted shares. ATH should be valued separately from compute operations.
Which DCF drivers deserve explicit scenarios?
| Valuation driver | Base evidence | DCF treatment |
|---|---|---|
| Contract conversion | $260M contract targeted for Q3 2026 deployment | Probability-weight deployment timing and revenue ramp rather than booking all value immediately. |
| Compute gross margin | Not yet demonstrated at scale | Build low, mid, and high margin cases after power, colocation, storage, networking, support, and depreciation. |
| Capital expenditure | Owned-infrastructure strategy disclosed after Q1 | Model hardware purchases, financing, maintenance, refresh cycles, and residual values explicitly. |
| Working capital | Deposits and monthly advance payments | Recognize favorable cash timing but preserve contract liabilities and performance obligations. |
| ATH treasury | $20.23M digital assets plus $15.37M receivable at March 31, 2026 | Value separately with liquidity, vesting, tax, custody, and price-haircut assumptions. |
| Share dilution | 5.54M common shares but 21.18M Q1 weighted-average denominator | Use a fully diluted share count consistent with pre-funded warrants, options, and likely financing. |
| Terminal economics | Rapid GPU innovation and customer concentration | Use conservative terminal margins and growth; test shorter asset lives and higher reinvestment. |
What is the key takeaway from Axe Compute analysis?
It matches enterprises needing specific GPUs and rapid deployment with distributed supply, then uses prepaid contracts to finance and monetize capacity. The $260 million agreement and additional $25.9 million of contracts matter far more to the future than Q1 revenue of $35,311.
Evidence remains incomplete: no full quarter of meaningful compute revenue, stable compute gross margin, positive operating cash flow has been reported. The March balance sheet was concentrated in ATH and token receivables, diluted shares exceed common shares outstanding.
What should students, researchers, and investors monitor next?
- Whether the 2,304-GPU B300 cluster enters service on the targeted schedule and begins producing approximately $21 million of quarterly revenue.
- Compute gross margin after power, storage, networking, colocation, support, financing, and depreciation.
- Operating cash flow and the gap between customer prepayments and infrastructure spending.
- The share of revenue from the largest customer and the pace of customer diversification.
- ATH fair value, vesting, liquidity, staking activity, and the effect on equity and reported earnings.
- New equity, debt, equipment finance, warrant exercises, and the fully diluted share count.
- The outcome of the Helomics strategic review and whether legacy costs decline.
- Uptime, deployment reliability, renewals, utilization, and the ability to redeploy GPUs after initial contracts expire.
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.
